Rapid acceleration of diagnostics (radx) -clinical evaluation services - clinical evaluation of projects 13091, 13454, 16345, 16404, and 16491

Ended Awarded Last action

Contract number
75N92023F00003
Awardee
Awarding agency
Obligated
$11,792,828

Award facts

Contract value 96% obligated
  • $11,792,828.17 Current, with exercised options
  • $12,253,680.17 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 · EOI:: implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI DE-obligation of no-year funds for… -$961,865
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $2,758,806
Original award $9,995,887

About this award

This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell. The $12,253,680.17 contract is for clinical evaluation services related to the Rapid Acceleration of Diagnostics (RADx) initiative, specifically for projects 13091, 13454, 16345, 16404, and 16491. Venturewell, a non-profit organization focused on supporting innovation and entrepreneurship, has extensive experience managing awards and operating commercialization centers for federal agencies, particularly within the NIH. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $58 million that Venturewell holds for RADx clinical evaluation services. The contract has a May 31, 2024 completion date and does not have a set-aside designation.

Quick answers

Who was awarded contract 75N92023F00003?

75N92023F00003 was awarded to National Collegiate Inventors & Innovators Alliance, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2023.

How much is contract 75N92023F00003 worth?

The government has obligated $11,792,828 on 75N92023F00003. Its potential value, with all options, is $12,253,680.

Is contract 75N92023F00003 an order under another contract?

Yes. 75N92023F00003 is a delivery order under 75N92022D00010, an indefinite delivery contract.

Was contract 75N92023F00003 competed?

The extent of competition for 75N92023F00003 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award